GAL and neoplasm: Since the natural anti-Gal antibody is present in all immunocompetent humans, it may be exploited to serve as a universal antibody for targeting vaccinating tumor cells to APC, provided that the tumor cells are manipulated to express α-gal epitopes [41,42].